We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+12.99%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$16.9B
AUM Growth
+$1.46B
Cap. Flow
-$312M
Cap. Flow %
-1.85%
Top 10 Hldgs %
20.99%
Holding
131
New
5
Increased
46
Reduced
74
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 26.83%
2 Healthcare 21.8%
3 Industrials 16.12%
4 Financials 13.53%
5 Consumer Staples 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XRAY icon
51
Dentsply Sirona
XRAY
$2.84B
$137M 0.81%
3,856,582
-13,270
-0.3% -$421K
ESE icon
52
ESCO Technologies
ESE
$7.77B
$134M 0.79%
1,145,601
-70,866
-6% -$7.45M
AKAM icon
53
Akamai
AKAM
$15.6B
$134M 0.79%
1,132,138
-170,415
-13% -$19M
SMAR
54
DELISTED
Smartsheet Inc.
SMAR
$132M 0.78%
2,761,845
+135,215
+5% +$5.76M
INSP icon
55
Inspire Medical Systems
INSP
$1.47B
$132M 0.78%
648,595
+179,050
+38% +$29M
SMPL icon
56
Simply Good Foods
SMPL
$907M
$122M 0.72%
3,084,944
-51,295
-2% -$1.92M
LW icon
57
Lamb Weston
LW
$7.42B
$119M 0.71%
1,104,300
+116,155
+12% +$11.2M
AXNX
58
DELISTED
Axonics, Inc. Common Stock
AXNX
$119M 0.71%
1,917,133
-96,268
-5% -$5.39M
PEN icon
59
Penumbra
PEN
$12.6B
$118M 0.7%
467,895
+114,505
+32% +$25.3M
NEOG icon
60
Neogen
NEOG
$2.05B
$113M 0.67%
5,597,791
+1,208,769
+28% +$20.5M
IDXX icon
61
Idexx Laboratories
IDXX
$44.9B
$112M 0.66%
200,946
-11,963
-6% -$5.62M
MSA icon
62
Mine Safety
MSA
$6.79B
$111M 0.66%
657,864
+75,035
+13% +$12.2M
MGPI icon
63
MGP Ingredients
MGPI
$403M
$107M 0.64%
1,090,231
+104,264
+11% +$10M
GMED icon
64
Globus Medical
GMED
$11.1B
$107M 0.63%
2,000,638
+83,262
+4% +$4.06M
SIGI icon
65
Selective Insurance
SIGI
$5.76B
$106M 0.63%
1,066,975
-60,005
-5% -$6.16M
IART icon
66
Integra LifeSciences
IART
$1.28B
$106M 0.63%
2,435,957
-2,872
-0.1% -$113K
CNMD icon
67
CONMED
CNMD
$1.3B
$105M 0.62%
957,325
+14,065
+1% +$1.45M
BRZE icon
68
Braze
BRZE
$3.02B
$104M 0.62%
1,956,160
+662,765
+51% +$32.8M
MZTI
69
The Marzetti Company
MZTI
$3.05B
$103M 0.61%
617,641
-33,688
-5% -$5.66M
LESL icon
70
Leslie's
LESL
$8.33M
$102M 0.61%
740,751
-26,355
-3% -$2.9M
AIN icon
71
Albany International
AIN
$2.09B
$102M 0.6%
1,033,720
+22,675
+2% +$1.98M
SXI icon
72
Standex International
SXI
$3.33B
$96.5M 0.57%
609,172
+37,339
+7% +$5.37M
IOSP icon
73
Innospec
IOSP
$2.09B
$96.1M 0.57%
779,565
-43,465
-5% -$4.63M
WST icon
74
West Pharmaceutical
WST
$23.7B
$93.6M 0.55%
265,755
-7,990
-3% -$2.83M
EPAC icon
75
Enerpac Tool Group
EPAC
$1.86B
$93.4M 0.55%
3,005,255
+2,462,360
+454% +$70.2M

Similar funds

Champlain Investment Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Champlain Investment Partners held 131 positions worth $16.9B, up 9.5% from $15.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Champlain Investment Partners's Q4 2023 filing shows 5 new, 46 increased, 74 reduced and 6 closed positions. Its largest new stake was Kinsale Capital Group: 153,265 shares worth $51.3M. The largest sale was New Relic, Inc., an estimated $169M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Champlain Investment Partners's largest Q4 2023 buy was Kinsale Capital Group: 153,265 shares worth $51.3M.
  • Champlain Investment Partners added most to Enerpac Tool Group in Q4 2023, an estimated $70.2M increase.
  • Champlain Investment Partners's biggest Q4 2023 reduction was Workday, cutting an estimated $100M.
  • Champlain Investment Partners fully exited New Relic, Inc. in Q4 2023, selling an estimated $169M.
  • Champlain Investment Partners's ten largest holdings make up 21% of its $16.9B portfolio in Q4 2023.
  • Champlain Investment Partners opened 5 new positions and closed 6 in Q4 2023.
  • Champlain Investment Partners's portfolio value rose 9.5% quarter-over-quarter to $16.9B.

Based on Champlain Investment Partners's 13F filing for Q4 2023, filed 13 Feb 2024.